SCHEMBL8279412

SCHEMBL8279412

Cc1ccc(-c2ccccc2CN)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DPP4 P27487 3/20 0.53
▸ NOS3 P29474 1/20 0.46
▸ NOS1 P29475 1/20 0.46
▸ NOS2 P35228 1/20 0.46
▸ PDK2 Q15119 1/20 0.43
▸ PRMT5 O14744 2/20 0.42
▸ WDR77 Q9BQA1 2/20 0.42
▸ HPGDS O60760 1/20 0.41
▸ NPC1 O15118 1/20 0.40
▸ PKM P14618 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ PTGS2 P35354 2/20 0.39
▸ F10 P00742 3/20 0.38
▸ TDO2 P48775 1/20 0.37
▸ TRPA1 O75762 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2E1 P05181 1/20 0.37
▸ CYP2A6 P11509 1/20 0.37
▸ CYP2B6 P20813 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8290925 0.80 CYP2D6 (0.49) CYP1A2CYP2C19
SCHEMBL8280206 0.80 DPP4 (0.50) DPP4NOS3NOS1NOS2PRMT5
SCHEMBL30607577 0.79 DPP4 (0.49) DPP4NOS3NOS1NOS2NPC1
SCHEMBL14007487 0.79 DPP4 (0.49) DPP4NPC1PKMTDO2CYP2A6
SCHEMBL30332418 0.78 DPP4 (0.47) DPP4NOS3NOS1NOS2F10
SCHEMBL1038044 0.76 DPP4 (0.69) DPP4NOS3NOS1NOS2NPC1
SCHEMBL16814937 0.76 DPP4 (0.49) DPP4NOS3NOS1NOS2
SCHEMBL27806948 0.76 DPP4 (0.53) DPP4NOS3NOS1NOS2F10
SCHEMBL3288789 0.75 DPP4 (0.62) DPP4PTGS2TDO2CYP1A2CYP2E1
SCHEMBL4446323 0.74 HPGD (0.50) PDK2HPGDSNPC1PKMRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005090354-A1 PYRAZOLO[3,4-b] PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS GLAXO GROUP LIMITED (GB) 2005-09-29 — — WO disclosed
Send feedback